Handel Biotage - BIOT CFD
Føj til favorit- Opsummering
- Historisk Data
- Begivenheder
- Resultatopgørelse
- Saldo
- Cash flow
- Ejerskab
Spænd | 1.9 | ||||||||
Long position, gebyr natten over
Long position overnight fee
Gå til platform | -0.025632% | ||||||||
Short position, gebyr natten over
Short position overnight fee
Gå til platform | -0.018813% | ||||||||
Gebyr natten over, tid | 22:00 (UTC) | ||||||||
Min. handlet mængde | 1 | ||||||||
Valuta | SEK | ||||||||
Margen | 20% | ||||||||
Aktiebørs | Sweden | ||||||||
Kommission på handel | 0% |
*Information provided by Capital.com
Biotage AB ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Tidligere luk* | 170.2 |
Åben* | 168.1 |
1-Års Ændring* | -13.26% |
Dagens Spænd* | 167.8 - 175.4 |
52-Ugers Spænd | 149.80-239.40 |
Gennemsnitlig Volumen (10 dage) | 67.05K |
Gennemsnitlig Volumen (3 måneder) | 1.85M |
Market Cap | 11.60B |
P/E-forhold | 48.66 |
Udestående aktier | 65.98M |
Omsætning | 1.52B |
EPS | 3.61 |
Dividend (Udbytte %) | 0.88168 |
Beta | 1.22 |
Næste indtjeningsopgørelse | Feb 15, 2023 |
Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Luk | Change | Change (%) | Åben | High | Low |
---|---|---|---|---|---|---|
Feb 3, 2023 | 174.8 | 6.6 | 3.92% | 168.2 | 175.5 | 166.7 |
Feb 2, 2023 | 170.2 | 5.9 | 3.59% | 164.3 | 171.7 | 163.2 |
Feb 1, 2023 | 161.8 | 1.3 | 0.81% | 160.5 | 163.7 | 159.9 |
Jan 31, 2023 | 159.9 | 1.5 | 0.95% | 158.4 | 160.5 | 157.0 |
Jan 30, 2023 | 160.3 | -0.9 | -0.56% | 161.2 | 161.8 | 157.5 |
Jan 27, 2023 | 161.8 | 2.7 | 1.70% | 159.1 | 162.3 | 159.1 |
Jan 26, 2023 | 160.5 | 3.7 | 2.36% | 156.8 | 162.0 | 156.8 |
Jan 25, 2023 | 158.5 | 1.8 | 1.15% | 156.7 | 158.5 | 154.8 |
Jan 24, 2023 | 157.3 | 1.1 | 0.70% | 156.2 | 162.7 | 155.5 |
Jan 23, 2023 | 156.2 | 1.8 | 1.17% | 154.4 | 157.9 | 153.9 |
Jan 20, 2023 | 152.2 | 1.0 | 0.66% | 151.2 | 153.7 | 147.6 |
Jan 19, 2023 | 152.7 | -2.8 | -1.80% | 155.5 | 157.6 | 150.9 |
Jan 18, 2023 | 156.8 | -7.5 | -4.56% | 164.3 | 165.4 | 152.6 |
Jan 17, 2023 | 172.4 | 1.9 | 1.11% | 170.5 | 172.9 | 168.5 |
Jan 16, 2023 | 173.8 | -1.9 | -1.08% | 175.7 | 176.1 | 170.0 |
Jan 13, 2023 | 175.1 | -1.8 | -1.02% | 176.9 | 177.2 | 171.3 |
Jan 12, 2023 | 170.5 | -3.5 | -2.01% | 174.0 | 175.5 | 169.2 |
Jan 11, 2023 | 174.0 | 0.5 | 0.29% | 173.5 | 177.2 | 172.4 |
Jan 10, 2023 | 173.5 | 0.7 | 0.41% | 172.8 | 175.6 | 171.4 |
Jan 9, 2023 | 173.9 | -0.6 | -0.34% | 174.5 | 177.1 | 172.1 |
Biotage Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Årlig
- Pr kvartal
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total omsætning | 667.912 | 748.147 | 910.896 | 1101.37 | 1092.28 | 1232 |
Omsætning | 667.912 | 748.147 | 910.896 | 1101.37 | 1092.28 | 1232 |
Kost af omsætning, Total | 282.098 | 291.483 | 354.27 | 415.963 | 425.55 | 477 |
Bruttofortjeneste | 385.814 | 456.664 | 556.626 | 685.41 | 666.728 | 755 |
Totale Driftsudgifter | 568.798 | 614.517 | 738.418 | 893.253 | 886.093 | 961 |
Salgs/Generelle/Admin. Udgifter, Total | 237.338 | 254.497 | 313.127 | 360.028 | 336.94 | 374 |
Forskning & Udvikling | 17.326 | 33.581 | 43.101 | 49.733 | 44.102 | 56 |
Depreciation / Amortization | 39.795 | 30.241 | 34.032 | 65.132 | 66.449 | 65 |
Renteudgift (Indkomst) - Netto Drift | -7.004 | -8.309 | -14.681 | -2.41 | -19.352 | -16 |
Usædvanlig Udgift (Indkomst) | 0 | 2.5 | 2.5 | |||
Other Operating Expenses, Total | -0.755 | 13.024 | 6.069 | 2.307 | 32.404 | 5 |
Driftsindtægter | 99.114 | 133.63 | 172.478 | 208.12 | 206.185 | 271 |
Renteindkomst (Udgift), Netto Ikke-Drift | -6.713 | 2.63 | 3.811 | 3.949 | -8.901 | -12 |
Andre, Netto | 0 | 0 | 0 | -0.077 | 25.445 | 10 |
Netto Indkomst Før Skat | 92.401 | 136.26 | 176.289 | 211.992 | 222.729 | 269 |
Netto Indkomst Efter Skat | 92.795 | 138.747 | 167.627 | 186.82 | 175.331 | 205 |
Netto Indkomst Før Ekstra Ting | 92.795 | 138.747 | 167.627 | 186.82 | 175.331 | 205 |
Netto Indkomst | 92.795 | 138.747 | 167.627 | 186.82 | 175.331 | 205 |
Total Adjustments to Net Income | 0.001 | |||||
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 92.796 | 138.747 | 167.627 | 186.82 | 175.331 | 205 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 92.796 | 138.747 | 167.627 | 186.82 | 175.331 | 205 |
Fortyndet Netto Indkomst | 92.796 | 138.747 | 167.627 | 186.82 | 175.331 | 205 |
Fortyndet Vægtet Gennemsnit Aktier | 64.7144 | 64.7144 | 64.7144 | 65.1821 | 65.2085 | 65.4648 |
Fortyndet EPS Uden Ekstraordinære Ting | 1.43393 | 2.14399 | 2.59026 | 2.86612 | 2.68877 | 3.13145 |
Dividends per Share - Common Stock Primary Issue | 1.25 | 1.4 | 1.5 | 0 | 1.5 | 1.55 |
Fortyndet Normaliseret EPS | 1.43393 | 2.14399 | 2.62699 | 2.89992 | 2.68877 | 3.17802 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Total omsætning | 281.35 | 303.458 | 305 | 342 | 386 |
Omsætning | 281.35 | 303.458 | 305 | 342 | 386 |
Kost af omsætning, Total | 103.889 | 121.281 | 122 | 130 | 145 |
Bruttofortjeneste | 177.461 | 182.177 | 183 | 212 | 241 |
Totale Driftsudgifter | 201.972 | 240.943 | 237 | 281 | 290 |
Salgs/Generelle/Admin. Udgifter, Total | 86.447 | 94.618 | 100 | 123 | 122 |
Forskning & Udvikling | 19.389 | 23.065 | 19 | 29 | 25 |
Other Operating Expenses, Total | -7.753 | 1.979 | -4 | -1 | -2 |
Driftsindtægter | 79.378 | 62.515 | 68 | 61 | 96 |
Renteindkomst (Udgift), Netto Ikke-Drift | -2.166 | -1.94 | -2 | 4 | -4 |
Netto Indkomst Før Skat | 77.212 | 60.575 | 66 | 65 | 92 |
Netto Indkomst Efter Skat | 60.039 | 45.973 | 53 | 46 | 71 |
Netto Indkomst Før Ekstra Ting | 60.039 | 45.973 | 53 | 46 | 71 |
Netto Indkomst | 60.039 | 45.973 | 53 | 46 | 71 |
Total Adjustments to Net Income | 0.001 | ||||
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 60.04 | 45.973 | 53 | 46 | 71 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 60.04 | 45.973 | 53 | 46 | 71 |
Fortyndet Netto Indkomst | 60.04 | 45.973 | 53 | 46 | 71 |
Fortyndet Vægtet Gennemsnit Aktier | 65.2304 | 65.2674 | 65.3455 | 66.016 | 65.9838 |
Fortyndet EPS Uden Ekstraordinære Ting | 0.92043 | 0.70438 | 0.81107 | 0.6968 | 1.07602 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 1.55 | 0 |
Fortyndet Normaliseret EPS | 0.92043 | 0.72531 | 0.81353 | 0.70752 | 1.07602 |
- Årlig
- Pr kvartal
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Totale Nuværende Aktiver | 355.98 | 409.252 | 494.438 | 586.569 | 751.615 | 774 |
Likvider og Kortsigtede Investeringer | 128.622 | 174.263 | 177.02 | 185.867 | 371.325 | 311 |
Likvider & Lignende | 128.622 | 174.263 | 177.02 | 185.867 | 371.325 | 311 |
Totale Tilgodehavender, Netto | 130.89 | 128.939 | 173.728 | 212.815 | 207.455 | 207 |
Accounts Receivable - Trade, Net | 118.348 | 118.191 | 156.042 | 197.651 | 194.018 | 180 |
Total Inventory | 88.906 | 95.794 | 132.338 | 173.76 | 159.823 | 237 |
Prepaid Expenses | 7.561 | 10.256 | 11.352 | 14.128 | 13.013 | 19 |
Other Current Assets, Total | 0.001 | -0.001 | -0.001 | |||
Total Assets | 695.196 | 757.201 | 1003.2 | 1335.69 | 1434.44 | 1992 |
Property/Plant/Equipment, Total - Net | 45.447 | 45.303 | 48.63 | 112.253 | 103.656 | 128 |
Property/Plant/Equipment, Total - Gross | 120.207 | 128.483 | 130.51 | 215.717 | 201.79 | 324 |
Accumulated Depreciation, Total | -74.76 | -83.18 | -81.88 | -103.464 | -98.134 | -196 |
Goodwill, Net | 104.023 | 104.023 | 186.055 | 315.869 | 290.209 | 741 |
Intangibles, Net | 116.015 | 118.646 | 192.654 | 260.047 | 250.787 | 313 |
Long Term Investments | 18.645 | 17.838 | 17.368 | 16.614 | 12.254 | 14 |
Note Receivable - Long Term | 1.156 | 0 | 0.003 | |||
Other Long Term Assets, Total | 53.93 | 62.139 | 64.055 | 44.335 | 25.92 | 22 |
Total Current Liabilities | 127.721 | 144.377 | 173.397 | 212.272 | 217.364 | 313 |
Accounts Payable | 38.133 | 47.457 | 54.764 | 41.461 | 51.236 | 56 |
Payable/Accrued | -0.001 | 0.001 | ||||
Accrued Expenses | 47.103 | 50.561 | 60.411 | 69.334 | 58.479 | |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 21.231 | 21.214 | 23 | ||
Other Current Liabilities, Total | 42.486 | 46.359 | 58.222 | 80.245 | 86.435 | 234 |
Total Liabilities | 131.958 | 148.59 | 301.023 | 460.184 | 444.403 | 621 |
Total Long Term Debt | 0 | 0 | 109.4 | 147.647 | 140.677 | 180 |
Deferred Income Tax | 1.759 | 1.621 | 14.78 | 28.884 | 32.838 | 73 |
Other Liabilities, Total | 2.478 | 2.592 | 3.446 | 71.381 | 53.524 | 55 |
Total Equity | 563.238 | 608.611 | 702.18 | 875.503 | 990.038 | 1371 |
Common Stock | 89.953 | 89.953 | 89.953 | 90.63 | 90.969 | 92 |
Retained Earnings (Accumulated Deficit) | 557.223 | 615.077 | 692.104 | 781.121 | 956.114 | 1063 |
Other Equity, Total | -83.938 | -96.419 | -79.877 | 3.752 | -116.547 | -50 |
Total Liabilities & Shareholders’ Equity | 695.196 | 757.201 | 1003.2 | 1335.69 | 1434.44 | 1992 |
Total Common Shares Outstanding | 64.7144 | 64.7144 | 64.7144 | 64.7144 | 65.2018 | 65.9838 |
Long Term Debt | 109.4 | 109.55 | 110 | 150 | ||
Capital Lease Obligations | 38.097 | 30.677 | 30 | |||
Additional Paid-In Capital | 59.502 | 266 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Totale Nuværende Aktiver | 851.273 | 694.254 | 784 | 774 | 842 |
Likvider og Kortsigtede Investeringer | 422.068 | 278.552 | 359 | 311 | 349 |
Likvider & Lignende | 422.068 | 278.552 | 359 | 311 | 349 |
Totale Tilgodehavender, Netto | 237.214 | 221.377 | 217 | 226 | 249 |
Accounts Receivable - Trade, Net | 204.607 | 191.724 | 181 | 226 | 216 |
Total Inventory | 191.992 | 194.326 | 208 | 237 | 244 |
Other Current Assets, Total | -0.001 | -0.001 | |||
Total Assets | 1575.81 | 1409.61 | 1503 | 1992 | 2056 |
Property/Plant/Equipment, Total - Net | 126.05 | 125.751 | 124 | 128 | 126 |
Goodwill, Net | 302.381 | 297.524 | 304 | 741 | 746 |
Intangibles, Net | 259.79 | 257.747 | 257 | 313 | 309 |
Long Term Investments | 12.263 | 12.224 | 12 | 14 | 15 |
Other Long Term Assets, Total | 24.051 | 22.115 | 22 | 22 | 18 |
Total Current Liabilities | 246.435 | 263.719 | 289 | 313 | 298 |
Accounts Payable | 53.503 | 46.03 | 54 | 56 | 43 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 22.653 | 23.289 | 24 | 23 | 23 |
Other Current Liabilities, Total | 170.279 | 194.4 | 211 | 234 | 232 |
Total Liabilities | 493.496 | 390.115 | 413 | 621 | 601 |
Total Long Term Debt | 153.626 | 40.861 | 37 | 180 | 175 |
Long Term Debt | 110 | 0 | 0 | 150 | 150 |
Capital Lease Obligations | 43.626 | 40.861 | 37 | 30 | 25 |
Deferred Income Tax | 36.325 | 36.86 | 37 | 73 | 72 |
Other Liabilities, Total | 57.11 | 48.675 | 50 | 55 | 56 |
Total Equity | 1082.31 | 1019.5 | 1090 | 1371 | 1455 |
Common Stock | 90.969 | 90.969 | 91 | 92 | 92 |
Additional Paid-In Capital | 60.137 | 61.239 | 64 | 266 | 269 |
Retained Earnings (Accumulated Deficit) | 1016.15 | 964.324 | 1017 | 1063 | 1134 |
Other Equity, Total | -84.948 | -97.032 | -82 | -50 | -40 |
Total Liabilities & Shareholders’ Equity | 1575.81 | 1409.61 | 1503 | 1992 | 2056 |
Total Common Shares Outstanding | 65.2018 | 65.2018 | 65.2018 | 65.9838 | 65.9838 |
- Årlig
- Pr kvartal
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Netto indkomst/Startlinje | 92.401 | 136.26 | 176.289 | 211.992 | 222.729 | 269 |
Likvider Fra Driftsaktiviteter | 139.072 | 168.932 | 155.005 | 211.807 | 279.047 | 353 |
Likvider Fra Driftsaktiviteter | 43.836 | 34.225 | 39.412 | 74.372 | 73.904 | 75 |
Ikke-Likvide Ting | -1.187 | 1.991 | -11.727 | 2.129 | -11.661 | 4 |
Cash Taxes Paid | 5.363 | 5.091 | 9.314 | 9.925 | 15.083 | 16 |
Likvid Rente Betalt | 0.023 | 0.002 | 1.738 | 2.86 | 3.339 | 3 |
Ændringer i Driftskapital | 4.022 | -3.544 | -48.969 | -76.686 | -5.925 | 5 |
Likvider fra Investeringsaktiviteter | -67.726 | -36.903 | -178.411 | -85.676 | -61.32 | -341 |
Kapitaludgifter | -47.54 | -37.804 | -47.158 | -45.454 | -60.941 | -56 |
Andre Investerings-Cash-Flow-Ting, Total | -20.186 | 0.901 | -131.253 | -40.222 | -0.379 | -285 |
Likvider fra Financieringsaktiviteter | -81.152 | -81.053 | 19.342 | -119.205 | -22.723 | -82 |
Total Cash Dividends Paid | -80.893 | -80.893 | -90.6 | -97.803 | 0 | -98 |
Udstedelse (Pensionering) af Gæld, Netto | -0.259 | -0.16 | 109.942 | -21.402 | -22.723 | 16 |
Udenlandsk Børs Effekter | 3.544 | -5.336 | 6.821 | 1.921 | -9.547 | 9 |
Netto Ændring i Likviditet | -6.262 | 45.64 | 2.757 | 8.847 | 185.457 | -61 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 77.212 | 137.787 | 204 | 269 | 92 |
Cash From Operating Activities | 67.62 | 159.904 | 249 | 353 | 57 |
Cash From Operating Activities | 17.133 | 35.656 | 54 | 75 | 23 |
Non-Cash Items | -1.912 | -2.579 | -5 | 4 | 5 |
Cash Taxes Paid | 4.569 | 8.686 | 14 | 16 | 15 |
Changes in Working Capital | -24.813 | -10.96 | -4 | 5 | -63 |
Cash From Investing Activities | -18.266 | -34.637 | -45 | -341 | -14 |
Capital Expenditures | -18.266 | -34.137 | -44 | -56 | -14 |
Other Investing Cash Flow Items, Total | 0 | -0.5 | -1 | -285 | 0 |
Cash From Financing Activities | -5.17 | -223.759 | -227 | -82 | -6 |
Issuance (Retirement) of Debt, Net | -5.17 | -125.956 | -129 | 16 | -6 |
Foreign Exchange Effects | 6.559 | 5.719 | 10 | 9 | 2 |
Net Change in Cash | 50.743 | -92.773 | -13 | -61 | 39 |
Total Cash Dividends Paid | -97.803 | -98 | -98 | 0 |
Investornavn | Investortype | Procent udestående | Aktiebeholdning | Aktieændring | Beholdningsdato | IOmsætningsscore |
---|---|---|---|---|---|---|
SEB Investment Management AB | Investment Advisor | 7.55 | 4981775 | -6598 | 2022-12-31 | LOW |
Swedbank Robur Fonder AB | Investment Advisor/Hedge Fund | 6.84 | 4513290 | -1505315 | 2022-12-31 | LOW |
Invesco Advisers, Inc. | Investment Advisor | 5.75 | 3794067 | -41121 | 2022-12-31 | LOW |
ODIN Forvaltning AS | Investment Advisor | 4.5 | 2969270 | -30730 | 2022-12-31 | LOW |
Didner & Gerge Fonder AB | Investment Advisor | 3.75 | 2474392 | 1493504 | 2022-12-31 | LOW |
Handelsbanken Kapitalförvaltning AB | Investment Advisor/Hedge Fund | 3.56 | 2349022 | -131968 | 2022-12-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.39 | 2236850 | 52787 | 2022-12-31 | LOW |
Lannebo Fonder AB | Investment Advisor/Hedge Fund | 3.24 | 2137874 | -26564 | 2022-12-31 | LOW |
Tredje AP Fonden | Pension Fund | 3.1 | 2045497 | 310124 | 2022-12-31 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 2.31 | 1524225 | -6599 | 2022-12-31 | LOW |
Första AP-Fonden | Pension Fund | 1.99 | 1313077 | -257337 | 2022-12-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.86 | 1227298 | 59385 | 2022-12-31 | LOW |
TIN Fonder | Investment Advisor | 1.53 | 1009552 | -10412 | 2022-12-31 | MED |
Montanaro Asset Management Limited | Investment Advisor | 1.37 | 903978 | 219232 | 2022-12-31 | LOW |
M & G Investment Management Ltd. | Investment Advisor | 1.25 | 824797 | 0 | 2022-12-31 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 1.14 | 752215 | -39590 | 2022-09-30 | LOW |
Goldman Sachs Asset Management, L.P. | Investment Advisor | 1.0636 | 701784 | -154 | 2022-11-30 | LOW |
DNCA Investments | Investment Advisor | 0.9396 | 620000 | -50224 | 2022-12-31 | LOW |
Danske Bank Asset Management | Investment Advisor | 0.9353 | 617175 | 15262 | 2022-12-31 | LOW |
Nordea Funds Oy | Investment Advisor | 0.8444 | 557198 | -45107 | 2022-12-31 | LOW |
Hvorfor vælge Capital.com? Vores tal taler for sig selv.
Capital.com GroupHandlende
Månedlkige, aktive klienter
Månedlig investeringsvolumen
Hævet hver måned
Handelslommeregner
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Biotage Company profile
Om Biotage
Biotage AB er en svensk baseret virksomhed, der udvikler og sælger systemer, forbrugsvarer og tjenester inden for biovidenskab. Virksomhedens kunder omfatter farmaceutiske og bioteknologiske virksomheder, virksomheder inden for fødevareindustrien og akademiske institutioner. Virksomheden tilbyder systemer og tjenester inden for tre områder: analytisk kemi, organisk kemi og industrielle harpikser. Biotages tilbud inden for analytisk kemi består af forbrugsvarer med tilhørende applikationer til at udtrække udvalgte stoffer fra forskellige typer prøver. Selskabets tilbud inden for organisk kemi omfatter produkter til farmaceutisk udvikling baseret på både små molekyler og peptider, og dets tilbud inden for industrielle harpikser består af polymerbaserede harpikser og forskningstjenester, der fører til udvikling og fremstilling af polymerbaserede materialer. Pr. 31. december 2013 drev selskabet 12 helejede datterselskaber på verdensplan.
Industry: | Medical Diagnostic & Testing Equipment |
Vimpelgatan 5
UPPSALA
UPPSALA 753 18
SE
Resultatopgørelse
- Annual
- Quarterly
Folk ser også
Leder du stadig efter en mægler, du kan stole på?
Deltag sammen med 485.000+ handlende over hele verden, der valgte at handle hos Capital.com